Phenotypes of chronic inflammatory demyelinating polyneuropathies with manifestation after coronavirus infection COVID-19
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an orphan disease of the peripheral nervous system. The clinical phenotypes of CIDP may influence the choice of primary pathogenetic therapy. In some cases, viral infection may be a trigger for the development of an immune-mediated process....
| Published in: | Клинический разбор в общей медицине |
|---|---|
| Main Authors: | Yana B. Kushnir, Alexander I. Bezvodinskikh, Anastasia V. Vladykina, Natalia A. Totolyan |
| Format: | Article |
| Language: | English |
| Published: |
LLC "MEDIAFORMAT"
2024-05-01
|
| Subjects: | |
| Online Access: | https://klin-razbor.ru/en/archive/2024/vol-5-5-2024/phenotypes-of-chronic-inflammatory-demyelinating-polyneuropathies-with-manifestation-after-coronavir_6745/?element |
Similar Items
Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)
by: R. A. Gapeshin, et al.
Published: (2021-02-01)
PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)
by: R. A. Gapeshin, et al.
Published: (2018-12-01)
The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)
by: R. A. Gapeshin, et al.
Published: (2020-06-01)
Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010-11-01)
by: J Gordon Millichap
Published: (2010-11-01)
ELECTRONEUROMYOGRAPHY EXAMINATION OF DIABETIC POLYNEUROPATHY PATIENTS
by: Siti Nurlaela, et al.
Published: (2019-01-01)
by: Siti Nurlaela, et al.
Published: (2019-01-01)
AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
by: Roman A. Gapeshin, et al.
Published: (2019-08-01)
by: Roman A. Gapeshin, et al.
Published: (2019-08-01)
Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)
Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)
by: A. S. Rizvanova, et al.
Published: (2020-03-01)
The Relationship between Quiescent Inflammatory Bowel Disease and Peripheral Polyneuropathy
Published: (2011-03-01)
Published: (2011-03-01)
Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-03-01)
by: J Gordon Millichap
Published: (2005-03-01)
Subacute Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-06-01)
by: J Gordon Millichap
Published: (2005-06-01)
A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)
by: Anna P. Patnaik, et al.
Published: (2021-02-01)
Acute Inflammatory Demyelinating Polyneuropathy: a comprehensive literature review
by: Karolina Serwońska, et al.
Published: (2025-03-01)
by: Karolina Serwońska, et al.
Published: (2025-03-01)
Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)
Genetic analyses of inflammatory polyneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy identified candidate genes
by: Zhaohui Du, et al.
Published: (2024-07-01)
by: Zhaohui Du, et al.
Published: (2024-07-01)
Chronic inflammatory demyelinating polyradiculoneuropathy overdiagnosis in Russia
by: Daria A. Grishina, et al.
Published: (2023-09-01)
by: Daria A. Grishina, et al.
Published: (2023-09-01)
A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy
by: Karissa L. Gable, et al.
Published: (2022-08-01)
by: Karissa L. Gable, et al.
Published: (2022-08-01)
Diagnostic transcranial magnetic stimulation in children with acute inflammatory demyelinating polyneuropathy
by: V. B. Voitenkov, et al.
Published: (2016-07-01)
by: V. B. Voitenkov, et al.
Published: (2016-07-01)
Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
by: Ivo Bozovic, et al.
Published: (2023-08-01)
by: Ivo Bozovic, et al.
Published: (2023-08-01)
Tuberculous spondylitis mimicking acute inflammatory demyelinating polyneuropathy: a rare presentation
by: N. A. Gajadeera, et al.
Published: (2025-03-01)
by: N. A. Gajadeera, et al.
Published: (2025-03-01)
Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—<i>A Systematic Review</i>
by: Elena-Sonia Moise, et al.
Published: (2022-07-01)
by: Elena-Sonia Moise, et al.
Published: (2022-07-01)
Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
by: Farzad Fatehi, et al.
Published: (2013-01-01)
by: Farzad Fatehi, et al.
Published: (2013-01-01)
Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy
by: Babita Gupta, et al.
Published: (2011-01-01)
by: Babita Gupta, et al.
Published: (2011-01-01)
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)
by: Jay Desai, et al.
Published: (2015-01-01)
Validation of the Medical Research Council sum score (MRCss) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
by: N. A. Suponeva, et al.
Published: (2023-03-01)
by: N. A. Suponeva, et al.
Published: (2023-03-01)
Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab
by: Lorraine Cafuir, et al.
Published: (2018-01-01)
by: Lorraine Cafuir, et al.
Published: (2018-01-01)
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses
by: Soo Jin Chang, et al.
Published: (2015-05-01)
by: Soo Jin Chang, et al.
Published: (2015-05-01)
Electroneurophysiological criteria of efficiency of pathogenetic therapy in diabetic polyneuropathy.
by: Lubov Kuzina, et al.
Published: (2016-12-01)
by: Lubov Kuzina, et al.
Published: (2016-12-01)
Colorectal carcinoma and chronic inflammatory demyelinating polyneuropathy: is there a possible paraneoplastic association?
by: Adnan Malik, et al.
Published: (2023-03-01)
by: Adnan Malik, et al.
Published: (2023-03-01)
Specific features of chronic inflammatory demyelinating polyneuropathy in children
by: A. L. Kurenkov, et al.
Published: (2015-02-01)
by: A. L. Kurenkov, et al.
Published: (2015-02-01)
Chronic Inflammatory Demyelinating Polyneuropathy Associated with Sirolimus in a Kidney Transplant Recipient
by: Sushrut Gupta, et al.
Published: (2025-07-01)
by: Sushrut Gupta, et al.
Published: (2025-07-01)
Focal Chronic Inflammatory Demyelinating Polyneuropathy – A Case Report with Clinical Application and Validation of 2021 European Academy of Neurology/Peripheral Nerve Society Criteria
by: Fu Liong Hiew, et al.
Published: (2025-01-01)
by: Fu Liong Hiew, et al.
Published: (2025-01-01)
Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies
by: Wiktoria Rałowska-Gmoch, et al.
Published: (2024-12-01)
by: Wiktoria Rałowska-Gmoch, et al.
Published: (2024-12-01)
Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
by: R. Bunevičiūtė, et al.
Published: (2020-06-01)
by: R. Bunevičiūtė, et al.
Published: (2020-06-01)
Impact of infections on the incidence of acute inflammatory demyelinating polyneuropathy in children
by: Hannah Gilbert, et al.
Published: (2023-06-01)
by: Hannah Gilbert, et al.
Published: (2023-06-01)
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
by: Chafké Belmokhtar, et al.
Published: (2019-03-01)
by: Chafké Belmokhtar, et al.
Published: (2019-03-01)
Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)
by: Cristina Gatcan, et al.
Published: (2023-12-01)
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT
by: А.L. Kurenkov, et al.
Published: (2014-10-01)
by: А.L. Kurenkov, et al.
Published: (2014-10-01)
Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy
by: N. B. Vuytsik, et al.
Published: (2017-02-01)
by: N. B. Vuytsik, et al.
Published: (2017-02-01)
Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
by: Guptill JT, et al.
Published: (2019-04-01)
by: Guptill JT, et al.
Published: (2019-04-01)
Similar Items
-
Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01) -
PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01) -
The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01) -
Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010-11-01) -
ELECTRONEUROMYOGRAPHY EXAMINATION OF DIABETIC POLYNEUROPATHY PATIENTS
by: Siti Nurlaela, et al.
Published: (2019-01-01)
